SF3B2 (Center) Rabbit Polyclonal Antibody
CAT#: AP53869PU-N
SF3B2 (Center) rabbit polyclonal antibody, Aff - Purified
Need it in bulk or conjugated?
Get a free quote
CNY 6314.00
货期*
2周
规格
Specifications
| Product Data | |
| Applications | WB |
| Recommend Dilution | ELISA: 1/1,000. Western blotting: 1/100-1/500. |
| Reactivity | Human |
| Host | Rabbit |
| Clonality | Polyclonal |
| Immunogen | KLH conjugated synthetic peptide between 515-545 amino acids from the Central region of Human SF3B2 |
| Specificity | Recognizes SF3B2 (Center). |
| Isotype | Ig |
| Formulation | PBS with 0.09% (W/V) Sodium Azide as preservative State: Aff - Purified State: Liquid purified Ig fraction |
| Concentration | lot specific |
| Purification | Protein A column followed by peptide Affinity purification |
| Conjugation | Unconjugated |
| Storage Condition | Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing. |
| Gene Name | splicing factor 3b subunit 2 |
| Database Link | |
| Background | This gene encodes subunit 2 of the splicing factor 3b protein complex. Splicing factor 3b, together with splicing factor 3a and a 12S RNA unit, forms the U2 small nuclear ribonucleoproteins complex (U2 snRNP). The splicing factor 3b/3a complex binds pre-mRNA upstream of the intron's branch site in a sequence-independent manner and may anchor the U2 snRNP to the pre-mRNA. Splicing factor 3b is also a component of the minor U12-type spliceosome. Subunit 2 associates with pre-mRNA upstream of the branch site at the anchoring site. Subunit 2 also interacts directly with subunit 4 of the splicing factor 3b complex. Subunit 2 is a highly hydrophilic protein with a proline-rich N-terminus and a glutamate-rich stretch in the C-terminus. [provided by RefSeq]. |
| Synonyms | Splicing factor 3B subunit 2,SAP145 |
| Note | Molecular Weight: 100228 Da |
| Reference Data | |
| Protein Pathways | Spliceosome |
Documents
| Product Manuals |
| FAQs |
| SDS |
Resources
| 抗体相关资料 |
Customer
Reviews
Loading...
